FGF-14
FGF-14 (FHF4) completes the intracrine FGF homologous factor subgroup. Highly expressed in cerebellar Purkinje and granule neurons, it binds Nav1.6 and shapes repetitive firing and synaptic transmission. Dominant FGF14 mutations cause spinocerebellar ataxia type 27, and deep-intronic repeat expansions in FGF14 have been identified as a frequent cause of late-onset cerebellar ataxia. FGF-14 also interacts with sodium channel auxiliary beta subunits to further fine-tune excitability. Autoantibodies against FGF14 occur in paraneoplastic neurological syndromes, and FGF14 variants have been linked to bipolar disorder risk in genetic studies. Recombinant FGF-14 supports ataxia research, Nav1.6 modulation assays and the development of autoantibody detection methods.
-
FGF-14 Recombinant Proteins (3)
- Species:
- Source:
August 31
-
Please select quantity
August 31
Get Quote
- Species:
- Source:
August 31
-
Please select quantity
August 31
Get Quote
- Species:
- Source:
August 31
-
Please select quantity
August 31
Get Quote
Recombinant Protein Expression Service
- Codon Optimization
- Gene Synthesis
- Construction of Expression Vector
- Strain Screening
- Protein Expression
- Purification & QC
- Protein Delivery
- Formula: Human
- Molecular Weight: Sf9 insect cells
The EpCAM/TROP1 protein serves as an important homogeneous interacting molecule that promotes direct contact between intestinal epithelial cells (IEC) and intraepithelial lymphocytes (IEL) in the mucosal epithelium. This feature helps establish an immune barrier against mucosal infections. EpCAM/TROP1 Protein, Human (His-SUMO) is the recombinant human-derived EpCAM/TROP1 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.
August 31
-
Please select quantity
August 31
Get Quote